单位:[1]National Integrated Traditional and Western Medicine Center for Cardiovascular Disease, China-Japan Friendship Hospital, Beijing, China[2]Department of Psychological Medicine, Wenzhou Seventh People’s Hospital, Wenzhou, China[3]Department of Psychological Medicine, Tianjin Anding Hospital, Tianjin, China[4]Department of Psychological Medicine, Tianjin Anning Hospital, Tianjin, China[5]Department of Psychological Medicine, Chinese People’s Liberation Army General Hospital, Chinese People’s Liberation Army Medical School, Beijing, China
Cardiac hypertrophy is a critical component of phenotype in the failing heart. Recently, increasing evidence has demonstrated that oxidative stress plays an important role in the pathogenesis of myocardial hypertrophy. In the present study, we generated a mouse model of transverse aortic constriction (TAC) to investigate whether hydrogen sulfide (H2S) has protective effects against cardiac hypertrophy. Left ventricular structure was analyzed by two-dimensional echocardiography. Oxidative stress was evaluated by measuring malondialdehyde, superoxide dismutase, glutathione peroxidase and reactive oxygen specie in the myocardium. Angiotensin II (Ang-II) was used to induce cardiomyocyte hypertrophy. Neonatal rat cardiomyocytes pretreated with H2S donor sodium hydrosulfide prior to Ang-II exposure were used to determine the involvement of Nrf2 and PI3K/Akt pathway in the antioxidant effects of H2S. Our findings showed that H2S could protect against cardiac hypertrophy by attenuating oxidative stress. The antioxidant roles of H2S in myocardial hypertrophy probably depend on the activation of PI3K/Akt signaling, which consequently increases Nrf2 activity and HO-1 and GCLM expression. In summary, H2S may exert antioxidant effect on cardiac hypertrophy via PI3K/Akt-dependent activation of Nrf2 pathway.
基金:
Found of Tianjin Health Bureau [2014KR02]; Chinese Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2012M0585]; Jiangsu Haosen pharmaceutical Limited by Share Ltd; Hainan Liou pharmaceutical Limited by Share Ltd; Xuzhou Enhua pharmaceutical Limited by Share Ltd; Shanghai Zhongxi pharmaceutical Limited by Share Ltd
第一作者单位:[1]National Integrated Traditional and Western Medicine Center for Cardiovascular Disease, China-Japan Friendship Hospital, Beijing, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Mingjing Shao,Chuanjun Zhuo,Ronghuan Jiang,et al.Protective effect of hydrogen sulphide against myocardial hypertrophy in mice[J].ONCOTARGET.2017,8(14):22344-22352.doi:10.18632/oncotarget.15765.
APA:
Mingjing Shao,Chuanjun Zhuo,Ronghuan Jiang,Guangdong Chen,Jianmin Shan...&Lirong Hu.(2017).Protective effect of hydrogen sulphide against myocardial hypertrophy in mice.ONCOTARGET,8,(14)
MLA:
Mingjing Shao,et al."Protective effect of hydrogen sulphide against myocardial hypertrophy in mice".ONCOTARGET 8..14(2017):22344-22352